Yilan Zeng

机构：Public Health Clinical Center of Chengdu, Zhengzhou People's Hospital · ORCID：0000-0001-5777-5702

发表论文 74 篇 · 总被引 1107 次 · h-index 15

代表论文

• Real‐world study on HBsAg loss of combination therapy in HBeAg ‐negative chronic hepatitis B patients (2022 · Journal of Viral Hepatitis · 被引 33)
• Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study (2022 · Emerging Microbes & Infections · 被引 31)
• An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir (2022 · Journal of Clinical and Translational Hepatology · 被引 17)
• Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials (2024 · Arab Journal of Gastroenterology · 被引 11)
• Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease profile of post-vaccination infection (2024 · Vaccine · 被引 10)
• Efficacy of pegylated interferon α-2b plus entecavir therapy and predictors of treatment success in children with chronic hepatitis B (2023 · Frontiers in Immunology · 被引 10)